12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga Insights 4 hours ago

Movers

Gainers Curis (NASDAQ:CRIS) shares moved upwards by 61.8% to $1.16 during Wednesday's regular session. The market value of their outstanding shares is at $1.7 million. Lyell Immunopharma (NASDAQ:LYEL) shares moved

Gainers

  • Curis (NASDAQ:CRIS) shares moved upwards by 61.8% to $1.16 during Wednesday's regular session. The market value of their outstanding shares is at $1.7 million.
  • Lyell Immunopharma (NASDAQ:LYEL) shares moved upwards by 47.63% to $15.9. The market value of their outstanding shares is at $263.9 million.
  • Neuronetics (NASDAQ:STIM) shares increased by 30.47% to $2.95. The market value of their outstanding shares is at $172.2 million. As per the press release, Q3 earnings came out today.
  • LivaNova (NASDAQ:LIVN) shares moved upwards by 22.08% to $97.55. The company's market cap stands at $4.3 billion. The company's, Q3 earnings came out today.
  • Burning Rock Biotech (NASDAQ:BNR) shares rose 21.57% to $13.3. The market value of their outstanding shares is at $115.3 million.
  • UFP Technologies (NASDAQ:UFPT) shares increased by 18.3% to $331.62. The company's market cap stands at $2.1 billion. The company's, Q3 earnings came out yesterday.

Losers

  • Nurix Therapeutics (NASDAQ:NRIX) stock decreased by 41.0% to $15.23 during Wednesday's regular session. The company's market cap stands at $2.8 billion.
  • Cerenome (NASDAQ:CNSY) shares decreased by 31.16% to $0.9. The company's market cap stands at $9.8 million.
  • CDT Equity (NASDAQ:CDT) stock fell 25.38% to $0.05.
  • BioVie (NASDAQ:BIVI) stock fell 24.86% to $1.3. The market value of their outstanding shares is at $15.0 million.
  • Syndax Pharmaceuticals (NASDAQ:SNDX) shares declined by 24.5% to $10.79. The market value of their outstanding shares is at $1.2 billion. As per the news, the Q3 earnings report came out 2 days ago.
  • aTyr Pharma (NASDAQ:ATYR) shares declined by 18.63% to $5.39. The company's market cap stands at $16.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Read the original